Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Specific Antibody Response”

Showing 12 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02982915
What this trial is testing

Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty

Who this might be right for
Aging Frailty
Longeveron Inc. 62
Early research (Phase 1)Study completedNCT00373412
What this trial is testing

Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge

Who this might be right for
Cytomegalovirus Infection
University of California, San Francisco 16
Testing effectiveness (Phase 2)Study completedNCT04566276
What this trial is testing

ChulaCov19 Vaccine in Healthy Adults

Who this might be right for
COVID-19 VaccineSafety Issues
Chulalongkorn University 192
Not applicableUnknownNCT04526977
What this trial is testing

Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis).

Who this might be right for
Covid19Immune SuppressionHIV-1-infection
Asociacion para el Estudio de las Enfermedades Infecciosas 90
Not applicableActive Not RecruitingNCT04852289
What this trial is testing

A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans

Who this might be right for
COVID-19
National Institute on Aging (NIA) 78
Early research (Phase 1)Study completedNCT06585891
What this trial is testing

Study of a Human Bispecific Antibody VRC-HIVMAB0121-00-AB (CAP256J3LS) Administered Intravenously or Subcutaneously to Healthy Adults

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Looking for participantsNCT06806033
What this trial is testing

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Who this might be right for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Hoffmann-La Roche 130
Early research (Phase 1)Study completedNCT00411580
What this trial is testing

Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 58
Not applicableStudy completedNCT01652066
What this trial is testing

Effect of a Mixture of Probiotics on the Antigen Specific Antibody Response in a Influenza Vaccination Model of Healthy Adults

Who this might be right for
Enhancement of Protective Antibody Response After Probiotic Consumption
Merck Medication Familiale 430
Not applicableStudy completedNCT04519710
What this trial is testing

Specific Anti-HBV Vaccine Response After Vaccination in Patients Requiring Anti-CD20 Monoclonal Antibodies

Who this might be right for
HBV
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 60
Very early researchStudy completedNCT03748524
What this trial is testing

Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine

Who this might be right for
Immunity, Cellular
Washington University School of Medicine 11
Not applicableStudy completedNCT04483908
What this trial is testing

COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses

Who this might be right for
COVID-19 Infection
University Hospital, Basel, Switzerland 477

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation